Case Report: Right−sided vagus nerve stimulation for treatment−resistant affective disorders with complex cardiac comorbidity - Scorecard - MDSpire

Case Report: Right−sided vagus nerve stimulation for treatment−resistant affective disorders with complex cardiac comorbidity

  • By

  • Christiane Licht

  • Michael Landgrebe

  • Tom Pieper

  • March 19, 2026

  • 0 min

Share

Clinical Scorecard: Right-Sided Vagus Nerve Stimulation in Treatment-Resistant Mood Disorders with Cardiac Complications

At a Glance

CategoryDetail
ConditionTreatment-resistant Major Depressive Disorder and Bipolar Depression with cardiac comorbidities
Key MechanismsNeuromodulation via electrical stimulation of the right cervical vagus nerve to stabilize mood
Target PopulationPatients with treatment-resistant affective disorders and contraindications to left-sided VNS due to cardiac or anatomical risks
Care SettingMultidisciplinary psychiatric and neurosurgical clinical settings with cardiological evaluation

Key Highlights

  • Right-sided VNS was used successfully in three patients with severe mood disorders and cardiac complications.
  • Significant mood stabilization and reduced hospitalizations were observed within 12 months post-implantation.
  • No serious cardiac adverse events or device interactions occurred during right-sided stimulation.

Guideline-Based Recommendations

Diagnosis

  • Identify treatment-resistant mood disorders after multiple failed pharmacological and psychotherapeutic trials.
  • Assess cardiac and anatomical contraindications to left-sided VNS implantation.

Management

  • Consider right-sided VNS implantation when left-sided approach is contraindicated due to cardiac conduction abnormalities, prior cardiac surgery or devices, or recurrent laryngeal nerve palsy.
  • Perform standard titration of stimulation parameters post-implantation.
  • Coordinate multidisciplinary team involvement including neurosurgery, neurology, psychiatry, and cardiology.

Monitoring & Follow-up

  • Long-term clinical follow-up to assess mood stabilization and hospital admission rates.
  • Monitor for cardiac adverse events such as bradyarrhythmia or device interactions.
  • Evaluate stimulation-related side effects like hoarseness or dyspnea.

Risks

  • Potential concerns about right-sided VNS affecting cardiac function, though no serious events observed in reported cases.
  • Risk of bilateral vocal cord dysfunction in patients with recurrent laryngeal nerve palsy.
  • Transient stimulation-related side effects.

Patient & Prescribing Data

Patients with treatment-resistant MDD or bipolar depression and significant cardiac or anatomical contraindications to left-sided VNS.

Right-sided VNS can provide lasting mood stabilization, reduce hospitalizations, and allow reduction or discontinuation of maintenance ECT without serious cardiac complications.

Clinical Best Practices

  • Use right-sided VNS only when left-sided implantation is contraindicated or carries unacceptable risk.
  • Conduct thorough multidisciplinary evaluation including cardiological and anatomical assessments before implantation.
  • Implement standard stimulation titration protocols and monitor patients closely for efficacy and safety.
  • Consider right-sided VNS as a viable alternative to expand treatment options for complex patients with treatment-resistant mood disorders.

References

Original Source(s)

Related Content